GSK To Maintain Avandia Sales Rep Totals After Bristol Copromotion Ends

GlaxoSmithKline will continue to support the anti-diabetic Avandia with 2000 sales reps after a copromotion agreement with Bristol-Myers Squibb ends Aug. 20

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet